|
TEG® Platelet Mapping™ assay variables (see text) and percent platelet receptor inhibition for healthy blood donors. |
|||
| All donors |
Females (n = 27) |
Males (n = 16) |
|
|
|
|||
| MAThrombin |
60.9 (4.5) |
62.8 (5.3) |
58.4 (5.4) * |
| MAFibrin |
7.5 (2.7) |
8.1 (2.8) |
6.6 (2.2) * |
| MAADP |
51.1 (8.1) |
52.7 (7.8) |
48.5 (8.1) |
| MAAA |
64.6 (4.7) |
66.1 (4.5) |
62.5 (4.3) |
| % ADP RIa |
18.6 (0–58.1) |
18.2 (0–58.1) |
19.4 (0–37.5) |
| % TxA2 RIa |
1.2 (0–10.1) |
1.3 (0–9.8) |
1.1 (0–10.1) |
|
Values are mean and SD or range aRI = receptor inhibition *Comparison between female and male donors, p < 0.05 | |||
Bochsen et al. Thrombosis Journal 2007 5:3 doi:10.1186/1477-9560-5-3 |
|||